Lung cancer is a common cancer, associated with a high mortality rate. Pleural effusions are common in lung cancer, developing in up to 40% of patients. Ascites is common in patients with abdominal malignancies and can be the presenting feature in up to 50% of patients. There is a need for new techniques to improve our diagnostic ability of cancer. FTIR technology could enable a point-of-care test that would provide an initial diagnosis that may determine a change in treatment at the time of the investigation.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
to detect signal difference between malignant and non-malignant pleural effusions
Timeframe: immediately after procedure
To detect a signal difference between malignant and non-malignant ascites
Timeframe: immediately after procedure
do detect signal difference between malignant and non-malignant pleural effusions
Timeframe: immediately after procedure
To detect a signal difference between malignant and non-malignant ascites
Timeframe: immediately after procedure